✦ LIBER ✦

Toxicity data in addition to survival data are important in evaluating the applicability of a chemotherapy regimen of advanced non-small-cell lung cancer

✍ Scribed by Hotta, Katsuyuki; Matsuo, Keitaro; Ueoka, Hiroshi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improving Survival and Reducing Toxicity

✍ Blackhall, Fiona H; Shepherd, Frances A; Albain, Kathy S 📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 172 KB

A Phase II Study of the Docetaxel–Carbop

✍ Nicolas Tsavaris; Christos Kosmas; Elias Skopelitis; Kostantinos Gennatas; Alexa 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 111 KB

Pemetrexed in the Treatment of Advanced

✍ Ralph G. Zinner; Roy S. Herbst 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 230 KB

CN2 ECONOMIC EVALUATION OF NEW POLY-CHEM

✍ N Neymark; J van Meerbeeck; E Smit; P Lianes; G Giaccone 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Impact of chemotherapy on survival in lo

✍ Cesne, A. Le; Chevalier, T. Le; Arriagada, R. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 522 KB

New chemotherapy agents in the treatment

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 140 KB